Solventum Corporation Common Stock (SOLV)

69.60
+0.56 (0.81%)
NYSE · Last Trade: May 6th, 3:44 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close69.04
Open68.01
Bid69.51
Ask69.69
Day's Range67.76 - 72.76
52 Week Range62.38 - 88.20
Volume1,500,716
Market Cap12.20B
PE Ratio (TTM)7.856
EPS (TTM)8.9
Dividend & YieldN/A (N/A)
1 Month Average Volume1,195,654

Chart

News & Press Releases

Solventum (SOLV) Q1 2026 Earnings Transcriptfool.com
Solventum (SOLV) Q1 2026 Earnings Transcript
Via The Motley Fool · May 6, 2026
SOLV Q1 Deep Dive: Portfolio Moves and Product Launches Shape Year Ahead
Healthcare solutions provider Solventum (NYSE:SOLV) reported Q1 CY2026 results topping the market’s revenue expectations, but sales fell by 3% year on year t...
Via StockStory · May 6, 2026
Solventum (NYSE:SOLV) Exceeds Q1 CY2026 Expectations
Healthcare solutions provider Solventum (NYSE:SOLV) reported Q1 CY2026 results exceeding the market’s revenue expectations, but sales fell by 3% year on year...
Via StockStory · May 5, 2026
Solventum Corp (NYSE:SOLV) Shares Flat After Q1 Beatchartmill.com
Via Chartmill · May 5, 2026
7 Bull Flag Setups Found With the ChartMill Stock Screenerchartmill.com
Via Chartmill · April 28, 2026
Solventum Q1 2026 Earnings Call: Complete Transcriptbenzinga.com
Via Benzinga · May 5, 2026
Solventum (SOLV) Reports Q1: Everything You Need To Know Ahead Of Earnings
Healthcare solutions provider Solventum (NYSE:SOLV) will be reporting earnings this Tuesday after the bell. Here’s what you need to know. Solventum beat anal...
Via StockStory · May 3, 2026
Solventum Stock Is Recovering: What's Going On?benzinga.com
Solventum shares are rebounding Thursday after activist investor Trian Fund criticized post‑spin performance and urged steps to unlock value.
Via Benzinga · April 30, 2026
Trian Calls on Solventum's Board to Create Value; Publishes Open Letter and Slide Deck
Solventum's Spin-Out from 3M has Maximized Executive Compensation, Not Shareholder Value
By Trian Fund Management, L.P. · Via GlobeNewswire · April 30, 2026
After a Volatile Run, Here's the Honest Buy, Sell, or Hold on 3Mfool.com
The stock of Industrial giant 3M has been a bit of a rollercoaster ride, and the ride may not be over.
Via The Motley Fool · April 26, 2026
Solventum Earnings Preview: What to Expect
Solventum will release its first-quarter earnings next month, and analysts anticipate a marginal bottom-line growth.
Via Barchart.com · April 23, 2026
Surgical Equipment & Consumables - Diversified Stocks Q4 Earnings: STERIS (NYSE:STE) Firing on All Cylinders
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at STERIS (NYSE:STE) and its pee...
Via StockStory · April 19, 2026
3M vs. United Parcel Service: One of These Industrial Stocks Is a Much Better Buy Right Nowfool.com
3M and UPS are iconic companies facing material headwinds, but one is expensive, and the other is cheap.
Via The Motley Fool · April 15, 2026
3 Reasons to Sell SOLV and 1 Stock to Buy Instead
Over the past six months, Solventum’s stock price fell to $67.18. Shareholders have lost 6% of their capital, which is disappointing considering the S&P 500 ...
Via StockStory · April 14, 2026
Surgical Equipment & Consumables - Diversified Stocks Q4 Recap: Benchmarking Solventum (NYSE:SOLV)
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, incl...
Via StockStory · April 12, 2026
1 Mid-Cap Stock Worth Investigating and 2 That Underwhelm
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...
Via StockStory · April 10, 2026
This Medical Device Stock Has Compounded at 13% Per Year for a Decadefool.com
Thermo Fisher Scientific has outpaced the medical device sector over the past decade.
Via The Motley Fool · April 7, 2026
1 Profitable Stock with Exciting Potential and 2 We Question
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via StockStory · April 6, 2026
Why Solventum (SOLV) Shares Are Sliding Today
What Happened? Shares of healthcare solutions provider Solventum (NYSE:SOLV) fell 3.7% in the afternoon session after Rothschild & Co initiated coverage on t...
Via StockStory · March 24, 2026
The 3M Rebirth: A Deep Dive into the Post-Spinoff Turnaround (2026)
As of March 19, 2026, 3M Company (NYSE: MMM) finds itself at a historic crossroads. Long regarded as the gold standard of American industrial innovation, the "Minnesota Mining and Manufacturing" giant spent much of the early 2020s beleaguered by massive litigation and a sprawling, inefficient corporate structure. However, today’s 3M is a leaner, more focused [...]
Via Finterra · March 19, 2026
1 Healthcare Stock with Exciting Potential and 2 We Ignore
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...
Via StockStory · March 18, 2026
3 of Wall Street’s Favorite Stocks with Open Questions
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...
Via StockStory · March 12, 2026
Investor Takes $14 Million Position in WEX as Fintech Firm Generates Record $2.7 Billion in Revenuefool.com
WEX delivers payment processing and software services for fleet, travel, and healthcare clients across the fintech landscape.
Via The Motley Fool · March 11, 2026
Thermon Stock Up 60% as Investor Builds $16 Million Position in the Industrial Heating Firmfool.com
Thermon Group Holdings delivers engineered heating solutions to process industries worldwide, serving sectors from energy to semiconductors.
Via The Motley Fool · March 11, 2026
Is 3M Stock Underperforming the S&P 500?
While 3M has underperformed the SPX over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.
Via Barchart.com · March 4, 2026